- Bone Morphogenetic Proteins
Bone Grafts Market was valued at USD 3.2 billion in 2022 and is expected to grow at a CAGR of 6.1% over 2023-29. Bone grafting is a surgical procedure used to fix bones or joints. Bone grafting is the replacement or repair of bones that are damaged due to trauma or fractures with the bones from other body tissue. For instance, in lumbar surgery, a bone from the donor site is transplanted to the recipient site to facilitate the fusion of vertebrae. The grafting tissue is necessary for osteoinduction, a natural bone healing process. Bone grafts are of three types autologous, allograft, and Synthetic bone. Autologous bone is harvested from the patient's own body, often from the iliac crest. Sallograft is cadaveric bone usually obtained from a bone bank. Synthetic bone made of hydroxyapatite or other naturally occurring, biocompatible substances. Bone grafts have a wide range of applications in sports, trauma plastic, facial, and spinal surgery. The market is expected to grow at steady state during the forecasting period. Companies focusing on product innovations and line extensions to increase their bone grafts market share. Increasing geriatric population and growing prevalence of bone and joint disorders are the main factors boosting the bone grafts market growth. According to National Osteoporosis Foundation (NOF), it is expected that the number of cases of osteoporosis will exceed 61 Mn by 2020. According to National Spinal Cord Injury Centre in the U.S., Researchers have assessed that in 2015, nearly 12,500 new spinal cord injuries occurred in the year. However, larger players in the market are funding bone graft research, collaborating, and acquiring smaller players to increase their market share.
Medtronic: Medtronic launched the Grafton Demineralized Bone Matrix (DBM) MatrixMold, a moldable bone grafting solution designed to support bone regeneration and healing in various orthopedic procedures. Medtronic acquired Titan Spine, a company specializing in surface-enhanced spinal interbody fusion technologies, to expand its portfolio of bone graft solutions.
DePuy Synthes (a Johnson & Johnson company): DePuy Synthes introduced the CONFORM SHEET, a 3D-printed titanium implant designed for bone reconstruction and fusion in orthopedic surgeries. DePuy Synthes launched the ACTIS Total Hip System, which incorporates advanced materials and features to enhance stability and range of motion in hip replacement procedures.
Stryker Corporation: Stryker introduced the Strut Allograft, a structural allograft solution for bone grafting procedures, providing stability and support during spinal fusion surgeries. Stryker acquired Wright Medical Group, expanding its orthopedic product portfolio, including bone grafts and other surgical solutions.
Zimmer Biomet: Zimmer Biomet launched the Vitality+ and Vitality+ HP Bioactive Bone Grafts, which are advanced bone graft substitutes that aim to enhance bone regeneration and provide a scaffold for new bone formation. Zimmer Biomet introduced the Persona IQ, a personalized knee system that utilizes advanced imaging and data analytics to optimize implant fit and alignment for better patient outcomes.
NuVasive Inc.: NuVasive focused on developing advanced spine implant systems and surgical solutions, including bone grafts, to improve spinal fusion outcomes and promote bone healing. NuVasive launched the Cohere XLIF, an interbody implant made of a porous polyetheretherketone (PEEK) material that promotes bone formation and integration in lateral lumbar interbody fusion procedures.
Fastest Growing Market
Increase in the incidence of bone & joint disorders, technological advancements in bone grafts, development of biocompatible synthetic bone grafts, and an increase in demand for dental bone grafts are expected to drive the market. People with diabetes are liable to suffer from joint disorders and osteoporosis and a person with obesity has 60% more susceptible to arthritis and other joint disorders. However, the high cost of surgeries and ethical issues related to bone grafting procedures expected to hinder the market growth over the forecast period. For instance, a study conducted by BioMed Central, BMC Medical Ethics found that out of 100 patients, about 20% of the patients not accepting allografts for their grafting surgery. The reasons for rejection was specific religious affiliations and people are not accepting bone from other animals for human benefit.
The bone grafts market size was valued at USD 3.2 billion in 2022
Stryker Corporation (U.S.), Regeneration Technologies, Inc.(U.S), NuVasive, Inc. (U.S.), NovaBone Products (U.S), Medtronic.(U.S.), Zimmer, Inc. (U.S.), LifeNet Health, Inc. (U.S.)
Europe is the fastest-growing region for the bone grafts market